AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1311666 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium metered dose aerosol 4 mg twice daily
Number of subjects: 35
Study 1311666 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 3923726 — intervention group
Group type: EXPERIMENTAL
Intervention: prazosin 20 mg/d orally (n = 12)
Number of subjects: 25
Study 3923726 — intervention group
Group type: COMPARATOR
Intervention: placebo (n = 13)
Number of subjects: 25
Study 30572270 — intervention group
Group type: EXPERIMENTAL
Intervention: Pea fiber (PF, 15 g/d in wafer form; n=29)
Number of subjects: 53
Study 30572270 — intervention group
Group type: COMPARATOR
Intervention: Control (CO, isocaloric amount of wafers; n=24)
Number of subjects: 53
Study 30572270 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 53
Study 30440874 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined visual feedback with pelvic assistance force
Number of subjects: 15
Study 30440874 — intervention group
Group type: COMPARATOR
Intervention: Visual feedback only
Number of subjects: 15
Study 26875069 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk rtPA mobile application
Number of subjects: 303
Study 23392978 — intervention group
Group type: EXPERIMENTAL
Intervention: B-ultrasound-guided CHIPC
Number of subjects: 62
Study 23392978 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopy-assisted CHIPC
Number of subjects: 62
Study 20939481 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual reduction combined with uni-lateral PKP
Number of subjects: 85
Study 20939481 — intervention group
Group type: COMPARATOR
Intervention: Simple uni-lateral PKP
Number of subjects: 85
Study 18725895 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet providing 13% of energy from sugars
Number of subjects: 19
Study 18725895 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet providing 30% of energy from sugars
Number of subjects: 19
Study 18725895 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet providing 50% of energy from sugars
Number of subjects: 19
Study 18725895 — intervention group
Group type: EXPERIMENTAL
Intervention: All diets (13%, 30%, 50% sugar)
Number of subjects: 19
Study 18725895 — intervention group
Group type: COMPARATOR
Intervention: BMI class (normal weight vs obese)
Number of subjects: 19
Study 16632811 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 60 mg/kg rectally and 40 mg/kg orally
Number of subjects: 120
Study 16632811 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen 2 mg/kg IV twice
Number of subjects: 120
Study 16632811 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of acetaminophen and ketoprofen
Number of subjects: 120
Study 16632811 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 120
Study 14636810 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathways Obesity Prevention Program (school-based physical activity intervention)
Number of subjects: 580
Study 14636810 — intervention group
Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 580
Study 10780130 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal preventive intervention for conduct disorder; specific dosage and duration not mentioned.
Number of subjects: 0
Study 10780130 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified; details not available.
Number of subjects: 0
Study 8737186 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine infusion (0.01 microgram/kg/min)
Number of subjects: 32
Study 8737186 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (10 mg as i.v. bolus)
Number of subjects: 32
Study 8737186 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine infusion followed by metoclopramide (10 mg bolus after 2 hours)
Number of subjects: 32
Study 8737186 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (4-hour)
Number of subjects: 32
Study 1419443 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol during CPB
Number of subjects: 20
Study 1419443 — intervention group
Group type: COMPARATOR
Intervention: Control (no propofol)
Number of subjects: 20
Study 3100822 — intervention group
Group type: EXPERIMENTAL
Intervention: Visible haematuria screening in the morning
Number of subjects: 418
Study 3100822 — intervention group
Group type: EXPERIMENTAL
Intervention: Visible haematuria screening in the afternoon with terminal urine samples
Number of subjects: 418
Study 29604894 — intervention group
Group type: EXPERIMENTAL
Intervention: Global ground-state potential energy surface (PES) for triplet O4 based on MS-CASPT2/maug-cc-pVTZ electronic structure calculations.
Number of subjects: 0
Study 29604894 — intervention group
Group type: EXPERIMENTAL
Intervention: Many-body approach with accurate O-O pairwise interaction and fit to 10,180 electronic structure data points.
Number of subjects: 0
Study 29604894 — intervention group
Group type: EXPERIMENTAL
Intervention: Geometries calculated for the fit include dissociative and vibrationally excited diatom-diatom collisions of O2.
Number of subjects: 0
Study 29901362 — intervention group
Group type: EXPERIMENTAL
Intervention: Talcum powder
Number of subjects: 50
Study 29901362 — intervention group
Group type: COMPARATOR
Intervention: Zinc oxide cream
Number of subjects: 50
Study 24399554 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (varenicline and bupropion SR)
Number of subjects: 506
Study 24399554 — intervention group
Group type: COMPARATOR
Intervention: Varenicline monotherapy
Number of subjects: 506
Study 23257348 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 22
Study 23257348 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 20446998 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength of Tobacco Control (SoTC)
Number of subjects: 39
Study 20446998 — intervention group
Group type: EXPERIMENTAL
Intervention: Resources for tobacco control
Number of subjects: 39
Study 20446998 — intervention group
Group type: EXPERIMENTAL
Intervention: Population size, percent Caucasian, tobacco production, smoking prevalence
Number of subjects: 39
Study 18343249 — intervention group
Group type: COMPARATOR
Intervention: CH-1504 (1, 5, 7.5, 10, 15, or 20 mg)
Number of subjects: 100
Study 18343249 — intervention group
Group type: COMPARATOR
Intervention: CH-1504 (7.5, 10, or 15 mg)
Number of subjects: 100
Study 19135235 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic mixture (2 lactobacilli, bifidobacteria, and propionibacteria)
Number of subjects: 1018
Study 19135235 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1018
Study 19135235 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic mixture
Number of subjects: 1018
Study 16005507 — intervention group
Group type: EXPERIMENTAL
Intervention: Eugenol-containing temporary cement (Temp bond) removed by excavator
Number of subjects: 140
Study 16005507 — intervention group
Group type: EXPERIMENTAL
Intervention: Eugenol-containing temporary cement (Temp bond) removed by sandblasting
Number of subjects: 140
Study 16005507 — intervention group
Group type: EXPERIMENTAL
Intervention: Eugenol-free temporary cement (Temp bond NE) removed by excavator
Number of subjects: 140
Study 16005507 — intervention group
Group type: EXPERIMENTAL
Intervention: Eugenol-free temporary cement (Temp bond NE) removed by sandblasting
Number of subjects: 140
Study 16005507 — intervention group
Group type: EXPERIMENTAL
Intervention: Total-etch bonding system (Excite/Variolink II)
Number of subjects: 140
Study 16005507 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etching primer system (Panavia F 2.0)
Number of subjects: 140
Study 16005507 — intervention group
Group type: COMPARATOR
Intervention: Control group - fresh dentin scratched by excavator
Number of subjects: 140
Study 16005507 — intervention group
Group type: COMPARATOR
Intervention: Control group - fresh dentin sandblasted
Number of subjects: 140
Study 16005507 — intervention group
Group type: COMPARATOR
Intervention: Control group - fresh dentin with no surface treatment
Number of subjects: 140
Study 11204899 — intervention group
Group type: EXPERIMENTAL
Intervention: Hidden speed cameras
Number of subjects: 0
Study 11204899 — intervention group
Group type: COMPARATOR
Intervention: Visible speed cameras
Number of subjects: 0
Study 9030363 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) plus Lamivudine (3TC)
Number of subjects: 620
Study 9030363 — intervention group
Group type: COMPARATOR
Intervention: Control treatments (other treatment arms)
Number of subjects: 620
Study 7967434 — intervention group
Group type: EXPERIMENTAL
Intervention: Erwinia L-asparaginase therapy
Number of subjects: 21
Study 7967434 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic use of anticoagulants (under investigation)
Number of subjects: 21
Study 3547386 — intervention group
Group type: EXPERIMENTAL
Intervention: Videotape version of the lesson
Number of subjects: 162
Study 3547386 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive video version of the lesson
Number of subjects: 162
Study 3547386 — intervention group
Group type: COMPARATOR
Intervention: Control group (questionnaire only)
Number of subjects: 162
Study 3547386 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental conditions (both videotape and interactive video)
Number of subjects: 162
Study 11952670 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical corticosteroid applied twice daily starting from day 4
Number of subjects: 20
Study 11952670 — intervention group
Group type: COMPARATOR
Intervention: Vehicle applied twice daily starting from day 4
Number of subjects: 20
Study 29660190 — intervention group
Group type: EXPERIMENTAL
Intervention: HBAI20 vaccine
Number of subjects: 34
Study 29660190 — intervention group
Group type: COMPARATOR
Intervention: HBVaxPro©‐10 μg vaccine
Number of subjects: 34
Study 27002062 — intervention group
Group type: EXPERIMENTAL
Intervention: Brivaracetam (150 mg single oral dose)
Number of subjects: 26
Study 27002062 — intervention group
Group type: COMPARATOR
Intervention: Rifampin (600 mg/day for 5 days)
Number of subjects: 26
Study 24297971 — intervention group
Group type: EXPERIMENTAL
Intervention: Social networks intervention (peer support, monthly diabetes education sessions)
Number of subjects: 138
Study 24297971 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard diabetes education sessions)
Number of subjects: 138
Study 22378892 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower limb amputation (painless)
Number of subjects: 18
Study 22378892 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile stimulation of the intact foot in amputees
Number of subjects: 18
Study 20167142 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP), 88 micrograms, twice daily
Number of subjects: 1052
Study 20167142 — intervention group
Group type: COMPARATOR
Intervention: Montelukast, 10 mg, daily
Number of subjects: 1052
Study 18560254 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural treatment and cognitive strategy training (8 group sessions each)
Number of subjects: 95
Study 18560254 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 95
Study 15958001 — intervention group
Group type: EXPERIMENTAL
Intervention: LigaSure
Number of subjects: 30
Study 15958001 — intervention group
Group type: COMPARATOR
Intervention: Conventional suture ligature
Number of subjects: 30
Study 12463081 — intervention group
Group type: EXPERIMENTAL
Intervention: Insoluble iodine skin preparation
Number of subjects: 0
Study 12463081 — intervention group
Group type: COMPARATOR
Intervention: Other skin preparation methods
Number of subjects: 0
Study 10338233 — intervention group
Group type: EXPERIMENTAL
Intervention: Trousseau dilator
Number of subjects: 30
Study 10338233 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracheal hook
Number of subjects: 30
Study 10338233 — intervention group
Group type: COMPARATOR
Intervention: Scalpel handle rotation
Number of subjects: 30
Study 7796217 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-session AIDS prevention program emphasizing risk education, sexual assertiveness, condom use, risk-related behavioral self-management, and problem-solving skills
Number of subjects: 52
Study 7796217 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 52
Study 1838750 — intervention group
Group type: EXPERIMENTAL
Intervention: Acitretin with PUVA
Number of subjects: 60
Study 1838750 — intervention group
Group type: COMPARATOR
Intervention: Placebo with PUVA
Number of subjects: 60
Study 7025883 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 (PGE2) vaginal pessaries (10 mg)
Number of subjects: 0
Study 7025883 — intervention group
Group type: COMPARATOR
Intervention: Prostaglandin E2 (PGE2) vaginal pessaries (5 mg)
Number of subjects: 0
Study 7025883 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31014294 — intervention group
Group type: EXPERIMENTAL
Intervention: Manualised Body Psychotherapy (BPT)
Number of subjects: 24
Study 31014294 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 24
Study 28764579 — intervention group
Group type: EXPERIMENTAL
Intervention: Foley catheter balloon (FCB) insertion
Number of subjects: 300
Study 28764579 — intervention group
Group type: COMPARATOR
Intervention: Intravaginal dinoprostone tablet placement
Number of subjects: 300
Study 27142588 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted temperature management (TTM) at 33 ± 1 °C for 48 hours
Number of subjects: 350
Study 27142588 — intervention group
Group type: COMPARATOR
Intervention: Targeted temperature management (TTM) at 33 ± 1 °C for 24 hours
Number of subjects: 350
Study 25116294 — intervention group
Group type: EXPERIMENTAL
Intervention: ICU admission from hospital ward
Number of subjects: 1500
Study 25116294 — intervention group
Group type: COMPARATOR
Intervention: ICU admission from emergency department
Number of subjects: 1500
Study 22024956 — intervention group
Group type: EXPERIMENTAL
Intervention: Creative arts as a complementary therapy
Number of subjects: 0
Study 20975465 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral nerve block
Number of subjects: 12
Study 20975465 — intervention group
Group type: COMPARATOR
Intervention: Sham block
Number of subjects: 12
Study 18407528 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosehip powder
Number of subjects: 287
Study 18407528 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 287
Study 16084806 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic exercise and continuous ultrasound (US)
Number of subjects: 120
Study 16084806 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic exercise and pulsed US
Number of subjects: 120
Study 16084806 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic muscular strengthening exercises
Number of subjects: 120
Study 16084806 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ultrasound)
Number of subjects: 120
Study 15334868 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogens
Number of subjects: 0
Study 15334868 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone
Number of subjects: 0
Study 15334868 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyproterone acetate
Number of subjects: 0
Study 15334868 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 0
Study 15334868 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 0
Study 15334868 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrostimulated acupuncture
Number of subjects: 0
Study 10725579 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetrorelix + recFSH
Number of subjects: 30
Study 10725579 — intervention group
Group type: COMPARATOR
Intervention: HMG
Number of subjects: 30
Study 8959592 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-planned social activities
Number of subjects: 20
Study 1559177 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy
Number of subjects: 72
Study 1559177 — intervention group
Group type: COMPARATOR
Intervention: Psychotherapy (Boys)
Number of subjects: 72
Study 1559177 — intervention group
Group type: COMPARATOR
Intervention: Psychotherapy (Girls)
Number of subjects: 72
Study 2865859 — intervention group
Group type: EXPERIMENTAL
Intervention: famotidine 40 mg nocte
Number of subjects: 185
Study 2865859 — intervention group
Group type: EXPERIMENTAL
Intervention: famotidine 20 mg bid
Number of subjects: 185
Study 2865859 — intervention group
Group type: EXPERIMENTAL
Intervention: famotidine 40 mg bid
Number of subjects: 185
Study 2865859 — intervention group
Group type: COMPARATOR
Intervention: ranitidine 150 mg bid
Number of subjects: 185
Study 30913204 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity treadmill exercise (MI)
Number of subjects: 282
Study 30913204 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 282
Study 30913204 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treadmill + resistance training (CT)
Number of subjects: 282
Study 30913204 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise (NON-EX)
Number of subjects: 282
Study 28675812 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone, 8 mg
Number of subjects: 15
Study 28675812 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac sodium, 50 mg associated with codeine, 50 mg
Number of subjects: 15
Study 27447477 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral diclofenac (50 mg) before and after ERCP
Number of subjects: 430
Study 27447477 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 430
Study 27447477 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral diclofenac (50 mg) in high-risk patients
Number of subjects: 430
Study 27447477 — intervention group
Group type: COMPARATOR
Intervention: Placebo in high-risk patients
Number of subjects: 430
Study 27447477 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral diclofenac (50 mg) in low-risk patients
Number of subjects: 430
Study 27447477 — intervention group
Group type: COMPARATOR
Intervention: Placebo in low-risk patients
Number of subjects: 430
Study 27447477 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral diclofenac (50 mg)
Number of subjects: 430
Study 25468186 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief CBT in addition to standard care
Number of subjects: 30
Study 25468186 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 30
Study 22668800 — intervention group
Group type: EXPERIMENTAL
Intervention: NT‐proBNP on admission
Number of subjects: 127
Study 22668800 — intervention group
Group type: EXPERIMENTAL
Intervention: Troponin T at discharge
Number of subjects: 127
Study 22668800 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge troponin T
Number of subjects: 127
Study 22668800 — intervention group
Group type: EXPERIMENTAL
Intervention: Admission NT‐proBNP
Number of subjects: 127
Study 20923960 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intravenous fat (32 g)
Number of subjects: 13
Study 20923960 — intervention group
Group type: EXPERIMENTAL
Intervention: High intravenous fat (64 g)
Number of subjects: 13
Study 20923960 — intervention group
Group type: EXPERIMENTAL
Intervention: Low oral fat (32 g)
Number of subjects: 13
Study 20923960 — intervention group
Group type: EXPERIMENTAL
Intervention: High oral fat (64 g)
Number of subjects: 13
Study 20923960 — intervention group
Group type: COMPARATOR
Intervention: Intravenous saline
Number of subjects: 13
Study 18351535 — intervention group
Group type: EXPERIMENTAL
Intervention: Microcoaxial phacoemulsification (MCP) with a 2.2 mm corneal incision width
Number of subjects: 109
Study 18351535 — intervention group
Group type: COMPARATOR
Intervention: Standard phacoemulsification with a 3.0 mm incision width
Number of subjects: 109
Study 15849296 — intervention group
Group type: EXPERIMENTAL
Intervention: Volleyball players (N=57)
Number of subjects: 57
Study 15849296 — intervention group
Group type: COMPARATOR
Intervention: Matched controls (N=55)
Number of subjects: 57
Study 12428181 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (CoQ) supplementation (100 mg twice daily for 12 weeks)
Number of subjects: 74
Study 12428181 — intervention group
Group type: COMPARATOR
Intervention: Fenofibrate (200 mg each morning for 12 weeks)
Number of subjects: 74
Study 9664865 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-focus condition
Number of subjects: 60
Study 9664865 — intervention group
Group type: COMPARATOR
Intervention: Other-focus condition
Number of subjects: 60
Study 9664865 — intervention group
Group type: COMPARATOR
Intervention: Social-focus condition
Number of subjects: 60
Study 7924476 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone (0.12 ppm)
Number of subjects: 15
Study 7924476 — intervention group
Group type: COMPARATOR
Intervention: Air (placebo)
Number of subjects: 15
Study 2803605 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction training
Number of subjects: 256
Study 2803605 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress inoculation training
Number of subjects: 256
Study 2803605 — intervention group
Group type: COMPARATOR
Intervention: No-contact control
Number of subjects: 256
Study 1065467 — intervention group
Group type: EXPERIMENTAL
Intervention: Craniocervical irradiation and intrathecal methotrexate
Number of subjects: 117
Study 29960005 — intervention group
Group type: EXPERIMENTAL
Intervention: dV‐Trainer
Number of subjects: 100
Study 29960005 — intervention group
Group type: COMPARATOR
Intervention: No‐dV‐Trainer
Number of subjects: 100
Study 27432113 — intervention group
Group type: EXPERIMENTAL
Intervention: Chain-loaded resistance (CLR) warm-up
Number of subjects: 16
Study 27432113 — intervention group
Group type: COMPARATOR
Intervention: Free-weight resistance (FWR) warm-up
Number of subjects: 16
Study 25074396 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency management
Number of subjects: 100
Study 25074396 — intervention group
Group type: COMPARATOR
Intervention: Spirometric lung age
Number of subjects: 100
Study 25074396 — intervention group
Group type: COMPARATOR
Intervention: Combined lung age and contingency management
Number of subjects: 100
Study 25074396 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study 25074396 — intervention group
Group type: COMPARATOR
Intervention: Non-contingency management
Number of subjects: 100
Study 22498212 — intervention group
Group type: COMPARATOR
Intervention: Radiation alone
Number of subjects: 204
Study 22498212 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation plus androgen deprivation therapy
Number of subjects: 204
Study 22498212 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate specific antigen nadir increase
Number of subjects: 204